SEARCH
Enter your search term below:
INSIGHTS / News
University spin-out “Azellon” announces recruitment phase of knee repair clinical trial
Azellon Ltd, (“Azellon”), a spin-out from the University of Bristol and the developer of stem cell therapies for tissue repair, today announced that recruitment had commenced for the phase I/IIa trial of its Cell Bandage for knee meniscus repair.
Built upon the pioneering work of Professor Anthony Hollander from the University’s School of Cellular and Molecular Medicine, the Azellon procedure takes stem cells, harvested from the patient’s own bone marrow, grows them on a structural bio-scaffold, and two weeks later implants the newly created Cell Bandage into the patient’s knee.
Read the full story on the University website
Mailing List sign-up
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close 
Mailing List sign-up
LATEST
TWEETS
You heard it here first. Take a peek at our latest newsletter: ow.ly/CLHr50BusYi@SETsquaredBath… twitter.com/i/web/status/13070…SETsquared #ScaleUp member @OxfordBrain was recently selected as a finalist by @nresearchnews & @merckgroup KGaA fo… twitter.com/i/web/status/13069…
“COVID-19 has moved the use of digital in NHS and healthcare forward by a decade.”@arjunpanesar CEO of… twitter.com/i/web/status/13069…
Day 3, looking forward to the final day of our online funded Innovation Workout. #ERDF #innovation #scaleup pic.twitter.com/UpjR3Hn92O
Fantastic to see that @SETsquaredExe member @minibems has attracted a new round of funding from its current investo… twitter.com/i/web/status/13068…
